CONTINGENCIES	6 Months Ended
Jun. 30, 2013
Commitments and Contingencies Disclosure [Abstract]
CONTINGENCIES	CONTINGENCIES In the ordinary course of business, the Company is subject to lawsuits, investigations, government inquiries and claims, including, but not limited to, product liability claims, advertising disputes and inquiries, consumer fraud suits, other commercial disputes, premises claims and employment and environmental, health, and safety matters. The Company records accruals for contingencies when it is probable that a loss will be incurred and can be reasonably estimated. Although MJN cannot predict with certainty the final resolution of these lawsuits, investigations and claims asserted against the Company, MJN does not believe any currently pending legal proceeding to which MJN is a party will have a material effect on the Company’s business or financial condition, although an unfavorable outcome in excess of amounts recognized as of June 30, 2013, with respect to one or more of these proceedings could have a material effect on the Company’s results of operations and cash flows for the periods in which a loss is recognized. The Company is not aware of any environmental, health or safety-related litigation or significant environmental, health and safety-related financial obligations or liabilities arising from current or former operations or properties that are likely to have a material impact on the Company’s business, financial position, results of operations or cash flows. Liabilities or obligations, which could require the Company to make significant expenditures, could arise in the future, however, as the result of, among other things, changes in, or new interpretations of, existing laws, regulations or enforcement policies, claims relating to on- or off-site contamination, or the imposition of unanticipated investigation or cleanup obligations. As previously announced, the Company is fully cooperating with the Bureau of Price Supervision and Anti-Monopoly of China's National Development and Reform Commission (“NDRC”) in its recent antitrust review of the infant formula industry's practices relating to resale prices (“China Antitrust Review”). Accordingly, the Company agreed to reduce the ex-factory price of certain products to its direct customers in China. The Company cannot predict what the NDRC's final resolution of this matter will be. Under China law, the NDRC has complete discretion, among other actions, to 1) issue an order prohibiting future conduct deemed illegal; and/or 2) confiscate proceeds deemed illegally obtained; and/or 3) assess a penalty in the range of 1 - 10% of a company's prior year sales in China. In 2012, MJN recorded approximately $800 million of sales in China. In accordance with Accounting Standards Codification 450-20, the Company has recorded a charge related to the China Antitrust Review. This charge did not have a material effect on the financial statements for the quarter ended June 30, 2013. However, the NDRC's final resolution of the matter could result in an incremental charge in excess of the amount recorded at June 30, 2013 and could have a material impact on the Company's operating results in the quarter in which such resolution is obtained. Based on the range of possible remedies under China law as described above, the Company determined that it cannot estimate a reasonably possible range for such a potential incremental charge. However, the Company believes that there would not be a material effect on its business, financial condition or cash flows if such an incremental charge were to be incurred.

CONTINGENCIES

In the ordinary course of business, the Company is subject to lawsuits, investigations, government inquiries and claims, including, but not limited to, product liability claims, advertising disputes and inquiries, consumer fraud suits, other commercial disputes, premises claims and employment and environmental, health, and safety matters.

The Company records accruals for contingencies when it is probable that a loss will be incurred and can be reasonably estimated. Although MJN cannot predict with certainty the final resolution of these lawsuits, investigations and claims asserted against the Company, MJN does not believe any currently pending legal proceeding to which MJN is a party will have a material effect on the Company’s business or financial condition, although an unfavorable outcome in excess of amounts recognized as of June 30, 2013, with respect to one or more of these proceedings could have a material effect on the Company’s results of operations and cash flows for the periods in which a loss is recognized.

The Company is not aware of any environmental, health or safety-related litigation or significant environmental, health and safety-related financial obligations or liabilities arising from current or former operations or properties that are likely to have a material impact on the Company’s business, financial position, results of operations or cash flows. Liabilities or obligations, which could require the Company to make significant expenditures, could arise in the future, however, as the result of, among other things, changes in, or new interpretations of, existing laws, regulations or enforcement policies, claims relating to on- or off-site contamination, or the imposition of unanticipated investigation or cleanup obligations.

As previously announced, the Company is fully cooperating with the Bureau of Price Supervision and Anti-Monopoly of China's National Development and Reform Commission (“NDRC”) in its recent antitrust review of the infant formula industry's practices relating to resale prices (“China Antitrust Review”). Accordingly, the Company agreed to reduce the ex-factory price of certain products to its direct customers in China. The Company cannot predict what the NDRC's final resolution of this matter will be. Under China law, the NDRC has complete discretion, among other actions, to 1) issue an order prohibiting future conduct deemed illegal; and/or 2) confiscate proceeds deemed illegally obtained; and/or 3) assess a penalty in the range of 1 - 10% of a company's prior year sales in China. In 2012, MJN recorded approximately $800 million of sales in China.

In accordance with Accounting Standards Codification 450-20, the Company has recorded a charge related to the China Antitrust Review. This charge did not have a material effect on the financial statements for the quarter ended June 30, 2013. However, the NDRC's final resolution of the matter could result in an incremental charge in excess of the amount recorded at June 30, 2013 and could have a material impact on the Company's operating results in the quarter in which such resolution is obtained. Based on the range of possible remedies under China law as described above, the Company determined that it cannot estimate a reasonably possible range for such a potential incremental charge. However, the Company believes that there would not be a material effect on its business, financial condition or cash flows if such an incremental charge were to be incurred.